Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease neurofibromatosis type 1
Comorbidity C0751690|malignant peripheral nerve sheath tumor
Sentences 16
PubMedID- 20664435 Conclusion: neurofibromatosis type 1 with malignant peripheral nerve sheath tumors complicating pregnancy requires an experienced, multidisciplinary team of care offering an aggressive evaluation to rule out malignant transformation or recurrence when there is any change in clinical status of a patient, as this may signal a potentially fatal change in the lesion.
PubMedID- 22745048 Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1.
PubMedID- 23161774 There are conflicting reports as to whether malignant peripheral nerve sheath tumor (mpnst) patients with neurofibromatosis type 1 (nf1) have worse prognosis than non-nf1 mpnst patients.
PubMedID- 22869071 A novel nf1 mutation in a chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
PubMedID- 23101443 Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
PubMedID- 26018702 Foreign body abscess mimicking a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.
PubMedID- 23244685 Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
PubMedID- 23483452 We used genome-wide serum mirna expression analysis to investigate the role of serum mirnas in distinguishing malignant peripheral nerve sheath tumor (mpnst) patients with and without neurofibromatosis type 1 (nf1) from nf1 patients.
PubMedID- 23292448 Since the bi-allelic inactivation of both neurofibromin 1 (nf1) gene alleles (nf1(-/-)) in schwann cells (scs) is common in both benign plexiform neurofibromas (pns) and malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1 (nf1), other genetic alterations in scs may be required for tumor progression of pns to mpnsts.
PubMedID- 23972085 Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
PubMedID- 23047517 Metastatic malignant peripheral nerve sheath tumor in neurofibromatosis type 1: a geriatric patient report.
PubMedID- 24343189 malignant peripheral nerve sheath tumor in neurofibromatosis type 1.
PubMedID- 20205747 malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report.
PubMedID- 23242059 Comparative effectiveness of 18f-fdg pet/ct versus whole-body mri for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
PubMedID- 26445379 Diagnostic accuracy of pet/ct-guided percutaneous biopsies for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients.
PubMedID- 24166582 Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.

Page: 1